Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-19 4:59 pm Purchase |
2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX |
Casdin Capital, LLC | 5,487,910 6.300% |
5,487,910 (New Position) |
Filing History |
| 2021-08-09 2:06 pm Purchase |
2021-07-29 | 13D | Tenaya Therapeutics, Inc. TNYA |
Casdin Capital, LLC | 3,586,818 8.700% |
3,586,818 (New Position) |
Filing History |
| 2021-08-03 5:16 pm Purchase |
2021-07-29 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 13,971,334 14.200% |
13,971,334 (New Position) |
Filing History |
| 2021-07-29 2:11 pm Purchase |
2021-06-17 | 13D | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,246,124 5.900% |
3,246,124 (New Position) |
Filing History |
| 2021-07-29 1:12 pm Purchase |
2021-07-21 | 13D | Absci Corporation ABSI |
Casdin Capital, LLC | 7,718,593 8.500% |
7,718,593 (New Position) |
Filing History |
| 2021-06-23 11:38 am Purchase |
2021-06-17 | 13G | Verve Therapeutics, Inc. VERV |
Casdin Capital, LLC | 3,038,167 6.600% |
3,038,167 (New Position) |
Filing History |
| 2021-02-11 10:28 am Sale |
2020-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Casdin Capital, LLC | 0 0.000% |
-2,160,000 (Position Closed) |
Filing History |
| 2021-02-11 10:25 am Purchase |
2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 3,346,035 6.930% |
247,913 (+8.00%) |
Filing History |
| 2021-02-11 10:23 am Purchase |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Casdin Capital, LLC | 1,241,176 4.520% |
1,891 (+0.15%) |
Filing History |
| 2021-02-11 10:19 am Purchase |
2020-12-31 | 13G | Invitae Corporation NVTAQ |
Casdin Capital, LLC | 12,298,038 6.370% |
3,264,095 (+36.13%) |
Filing History |
| 2021-02-11 10:17 am Sale |
2020-12-31 | 13G | DermTech, Inc. DMTKQ |
Casdin Capital, LLC | 1,370,000 6.990% |
-58,571 (-4.10%) |
Filing History |
| 2021-02-11 10:12 am Sale |
2020-12-31 | 13G | Codexis, Inc. CDXS |
Casdin Capital, LLC | 4,330,000 6.820% |
-743,780 (-14.66%) |
Filing History |
| 2020-11-27 5:21 pm Purchase |
2020-11-24 | 13D | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 7,440,107 22.700% |
3,066,774 (+70.12%) |
Filing History |
| 2020-06-01 1:14 pm Purchase |
2020-05-27 | 13G | DermTech, Inc. DMTKQ |
Casdin Capital, LLC | 1,428,571 7.900% |
1,428,571 (New Position) |
Filing History |
| 2020-05-18 6:15 pm Purchase |
2020-05-14 | 13G | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 4,373,333 18.200% |
1,904,762 (+77.16%) |
Filing History |
| 2020-05-18 4:18 pm Sale |
2020-05-12 | 13D | GENMARK DIAGNOSTICS INC GNMK |
Casdin Capital, LLC | 2,555,000 4.100% |
-810,000 (-24.07%) |
Filing History |